On June 20, 2026, the Adekunle Gold Foundation conducted its quarterly sickle cell medical outreach at the Akerele Medical Centre in Surelere, Lagos State, providing medical support to over 500 individuals living with sickle cell disease. This initiative was carried out in partnership with the Sickle Cell Advocacy & Management Initiative, coinciding with World Sickle Cell Day.

The Ministry of Health in Uganda has announced the arrival of an additional 19,200 doses of lenacapavir, a long-acting injectable drug for HIV prevention, due to increasing demand. This shipment is expected next month and will primarily be used for administering second injections to individuals already receiving the treatment.

Uganda is facing a growing cancer burden, with over 37,000 new diagnoses and nearly 28,000 deaths annually, according to recent estimates. Cervical cancer is the leading cause of cancer deaths among women, while prostate cancer is the most prevalent among men. This situation is putting significant pressure on patients, families, and the healthcare system.

President Samia Suluhu Hassan announced plans to expand cancer treatment services to improve public access and alleviate patient burdens. During the inauguration of a new radiotherapy unit, she also called for research into the rising cases of cancer and heart diseases among children.

A new report suggests that governments and global health donors should explore the potential of private pharmacies as a means to enhance access to care for HIV, tuberculosis, and malaria. This recommendation comes in light of decreasing funding for public health systems globally. The report is titled "Private Pharmacies as a Delivery Channel for HIV, TB, and Malaria Care."

The Ministry of Health reported that the demand for Lenacapavir, an HIV prevention injection introduced in Uganda in April, is surpassing the available supplies. Dr. Herbert Kadama, the ministry’s coordinator for Pre-Exposure Prophylaxis, noted that an increasing number of men are seeking the drug. This announcement was made during a meeting with HIV advocates, researchers, and policymakers.